FDA and IP
May 25th at 11:00am ET
Speakers: Brian Malkin | Chris Bruno | April Weisbruch

Life sciences organizations have become some of the world’s most watched businesses and the industry as a whole is facing heightened scrutiny in light of the COVID-19 pandemic.

The transactional and regulatory issues as well as the enforcement risks facing life science companies have grown in complexity, and there are many legal and business factors that life sciences companies and their leaders must monitor closely to succeed in this competitive and high-stakes business environment.

McDermott Will & Emery’s Life Sciences Bootcamp Series brings together our cross-disciplinary team of seasoned attorneys for one hour CLE programs tailored for life sciences in-house counsel to proactively address the wide variety of regulatory and enforcement issues projected to impact their businesses in 2021 and beyond.